Modifiable factors for somatic symptom persistence in patients with somatic symptom disorder: study protocol for a longitudinal cohort with an embedded ecologically momentary assessment (SOMA.SSD)
Nestoriuc Y, Pauls F, Blankenburg K, Hahn S, Wittenbecher H, Löwe B, Toussaint A.
BMJ Open. 2024; 17;14(11):e083500. doi: 10.1136/bmjopen-2023-083500.

Find the publication here

Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis.
Löwe B, Levenson J, Depping M, Hüsing P, Kohlmann S, Lehmann M, Shedden-Mora M, Toussaint A, Uhlenbusch N, Weigel A.
PSYCHOL MED. 2021 Nov 15:1-17.

Find the publication here

Persistence rate of DSM-5 somatic symptom disorder: 4-year follow-up in patients from a psychosomatic outpatient clinic.
Behm AC, Hüsing P, Löwe B, Toussaint A.
COMPR PSYCHIATRY. 2021 Oct;110:152265.

Find the publication here

Detecting DSM-5 somatic symptom disorder: criterion validity of the Patient Health Questionnaire-15 (PHQ-15) and the Somatic Symptom Scale-8 (SSS-8) in combination with the Somatic Symptom Disorder - B Criteria Scale (SSD-12).
Toussaint A, Hüsing P, Kohlmann S, Löwe B.
PSYCHOL MED 2020; 50(2):324–33.

Find the publication here

A European Research Agenda for Somatic Symptom Disorders, Bodily Distress Disorders, and Functional Disorders: Results of an Estimate-Talk-Estimate Delphi Expert Study.
van der Feltz-Cornelis CM, Elfeddali I, Werneke U, Malt UF, van den Bergh O, Schaefert R,…, Löwe B.
FRONT PSYCHIATRY 2018; 9:151.

Find the publication here

Facilitating adherence to endocrine therapy in breast cancer: stability and predictive power of treatment expectations in a 2-year prospective study.
Pan Y, Heisig SR, Blanckenburg P von, Albert U-S, Hadji P, Rief W, Nestoriuc Y.
BREAST CANCER RES TREAT 2018; 168(3):667–77.

Find the publication here

Validity of the Somatic Symptom Disorder-B Criteria Scale (SSD-12) in primary care.
Toussaint A, Riedl B, Kehrer S, Schneider A, Löwe B, Linde K.
FAM PRACT 2018; 35(3):342–7.

Find the publication here

Functional Somatic Symptoms Across Cultures: Perceptual and Health Care Issues.
Löwe B, Gerloff C.
PSYCHOSOM MED 2018; 80(5):412–5.

Find the publication here

Monitoring somatic symptoms in patients with mental disorders: Sensitivity to change and minimal clinically important difference of the Somatic Symptom Scale - 8 (SSS-8).
Gierk B, Kohlmann S, Hagemann-Goebel M, Löwe B, Nestoriuc Y.
GEN HOSP PSYCHIATRY 2017; 48:51–5.

Find the publication here

Is it best to expect the worst? Influence of patients' side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort study.
Nestoriuc Y, von Blanckenburg P, Schuricht F, Barsky AJ, Hadji P, Albert U-S et al.
ANN ONCOL 2016; 27(10):1909–15.

Find the publication here

Development and Validation of the Somatic Symptom Disorder-B Criteria Scale (SSD-12).
Toussaint A, Murray AM, Voigt K, Herzog A, Gierk B, Kroenke K, Rief W, Henningsen P, Löwe B. PSYCHOSOM MED 2016;78(1):5-12.

Find the publication here

Framing and personalizing informed consent to prevent negative expectations: An experimental pilot study.
Heisig SR, Shedden-Mora MC, Hidalgo P, Nestoriuc Y.
HEALTH PSYCHOLOGY 2015; 34(10):1033–7.

Find the publication here

Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines.
Nestoriuc Y, Orav EJ, Liang MH, Horne R, Barsky AJ.
ARTHRITIS CARE RES 2010; 62:791–9.

Find the publication here